Annovis Bio, Inc.
Annovis Bio, Inc.（ANVS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ANVS · 截至 2026年6月9日
活动摘要
买入笔数
19
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Annovis Bio, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ANVS 季度内部人买卖趋势
ANVS 内幕交易卖出 · ANVS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ANVS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ANVS 高管卖出股份 · ANVS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 20, 2026 | Hoffman Michael B Director | Purchase | 54,933 | $104K | Form 4 |
| May 20, 2026 | Hoffman Michael B Director | Purchase | 18,849 | $34K | Form 4 |
| May 20, 2026 | Hoffman Michael B Director | Purchase | 2,562 | $4K | Form 4 |
| Apr 2, 2026 | Hoffman Michael B Director | Purchase | 713,800 | $1.50M⚡ | Form 4 |
| Dec 8, 2025 | Hoffman Michael B Director | Purchase | 15,000 | $64K | Form 4 |
| Dec 8, 2025 | Hoffman Michael B Director | Purchase | 30,000 | $130K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 28,096 | $117K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 415 | $2K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 9,200 | $35K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 1,489 | $6K | Form 4 |
| Nov 21, 2025 | Hoffman Michael B Director | Purchase | 10,000 | $35K | Form 4 |
| Nov 21, 2025 | Hoffman Michael B Director | Purchase | 10,000 | $35K | Form 4 |
| Nov 14, 2025 | Hoffman Michael B Director | Purchase | 15,000 | $32K | Form 4 |
| Oct 28, 2025 | Maccecchini Maria-Luisa President & CEO · Director | Purchase | 97,561 | $200K | Form 4 |
| Oct 28, 2025 | Hoffman Michael B Director | Purchase | 975,610 | $2.00M⚡ | Form 4 |
| Sep 10, 2025 | Bruck Claudine Director | Option | 7,142 | $1000 | Form 4 |
| Aug 29, 2025 | Hoffman Michael B Director | Award | 5,000 | $12K | Form 4 |
| Aug 29, 2025 | Hoffman Michael B Director | Award | 5,000 | $11K | Form 4 |
| Aug 29, 2025 | Hoffman Michael B Director | Award | 5,000 | $11K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 1,100 | $3K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 5,545 | $14K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 5,283 | $14K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 6,717 | $17K | Form 4 |
| Jun 16, 2025 | Walsh Andrew Vice President, Finance | Award | 500 | $1K | Form 4 |
| Jun 13, 2025 | Hoffman Michael B Director | Award | 1 | $3 | Form 4 |
Maccecchini Maria-Luisa
President & CEO · Director
日期
Oct 28
股数
97,561
均价
$2.05
总金额
$200K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ANVS 内幕交易
ANVS 内幕交易
Annovis Bio, Inc.（ANVS）内幕交易数据来源于公司内部人（包括Hoffman Michael B (Director), Maccecchini Maria-Luisa (President & CEO · Director), Bruck Claudine (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ANVS内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Annovis Bio, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ANVS 内幕交易 · 5个问题Annovis Bio, Inc.（ANVS）的内部人包括高管和董事，如Hoffman Michael B (Director), Maccecchini Maria-Luisa (President & CEO · Director), Bruck Claudine (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026